Source comparison
Thymosin Alpha-1 vs LL-37 vs Combination Protocol: Immune Marker Comparison
CD4+ T-cell proliferation (% increase at 72hr) 35–50% 5–10% 40–55% Tα1 drives this metric; LL-37 adds minimal contribution Neutrophil chemotaxis (fold-increase) 1.2–1.5× 3.5–4.2× 4.0–4.8× LL-37 dominates; combination shows slight additive effect IL-2 productio
This comparison does not assign a generated winner or score.
- CD4+ T-cell proliferation (% increase at 72hr)
- 35–50%
- 5–10%
- 40–55%
- Tα1 drives this metric; LL-37 adds minimal contribution
- Neutrophil chemotaxis (fold-increase)
- 1.2–1.5×
- 3.5–4.2×
- 4.0–4.8×
- LL-37 dominates; combination shows slight additive effect
- IL-2 production (pg/mL increase)
- 180–220
- 20–40
- 200–240
- Tα1-dependent; LL-37 contributes minor upregulation
- Biofilm disruption (% reduction at 12hr)
- 10–15%
- 60–75%
- 65–80%
- LL-37 mechanism; Tα1 provides negligible direct effect
- Infection clearance time (days, bacterial model)
- 8–10
- 6–8
- 4.5–6
- Synergy visible here. Combination outperforms either alone by 25–40%
- Professional Assessment
- Strong adaptive priming but slow pathogen clearance
- Rapid innate response but no long-term immunity
- Dual-axis coverage. Adaptive scaffolding + immediate pathogen reduction